Frontlight ResearchEarly access
Trial site
UT Southwestern Medical Center at Dallas
- 5running trials
- 4closed trials
The trials here
What the 9 trials at this site are about, from their registry records.
- Conditions
- Bladder cancer3 trials
- Diabetic foot ulcer2 trials
- Acute myeloid leukaemia1 trial
- Lung cancer1 trial
- Melanoma1 trial
- Pancreatic cancer1 trial
- Phase
- Phase 32 trials
- Phase 11 trial
- Phase 21 trial
- Status
- Recruiting4 trials
- Completed2 trials
- Active, not recruiting1 trial
- Terminated1 trial
- Withdrawn1 trial
- Lead sponsor
- Cedars-Sinai Medical Center3 trials
- Astellas Pharma Global Development, Inc.2 trials
- University of Texas Southwestern Medical Center2 trials
- Alice Mims1 trial
- Pfizer1 trial
Running trials
Recruiting
Recruiting
A Study of Gilteritinib in Adults With Advanced ALK-positive Non-small Cell Lung Cancer (NSCLC)
Recruiting
Recruiting
A Novel Multiplex ELISA Assay for Evaluating Patients With Microscopic Hematuria for Bladder Cancer
Recruiting
A Novel Multiplex ELISA Assay for Surveilling Patients With History of Bladder Cancer
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Acute myeloid leukaemia1 recruiting
- Bladder cancer1 recruiting
- Lung cancer1 recruiting
- Pancreatic cancer1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 15 Nov 2026